Neurelis completes dosing in intranasal diazepam formulation study
Links shared publicly online about this topic.
- 349total visits
Neurelis completes dosing in intranasal diazepam formulation study
Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.
View full resource at news-medical.net
Tags: Seizure, Epilepsy, Anxiety Medication, Valium, Pharmacokinetics, News
Most Recently Shared on April 21, 2011 at 9:25 am By:
Epilepsy News: Neurelis completes dosing in intranasal diazepam formulation study: Neurelis, Inc. today announce... http://bit.ly/hgHafP
Neurelis Announces Completion Of Dosing In Study Of Intranasal Diazepam
medicalnewstoday.com — “Neurelis, Inc. announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulati” View full resource at medicalnewstoday.com
Most Recently Shared on April 22, 2011 at 9:05 am By:
MNT Pharma News Pharma and Health News
Neurelis Announces Completion Of Dosing In Study Of Intranasal Diazepam http://mnt.to/3TX3 #pharma #pharmaceutical
Advertisement
